Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma.

Nell RJ, Menger NV, Versluis M, Luyten GPM, Verdijk RM, Madigan MC, Jager MJ, van der Velden PA

Open source

DOI
10.1186/s12885-021-07865-x
Published
2021 Feb 15
Container
BMC cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-021-07865-x,
  title = {Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma.},
  author = {Nell RJ and Menger NV and Versluis M and Luyten GPM and Verdijk RM and Madigan MC and Jager MJ and van der Velden PA},
  year = {2021},
  journal = {BMC cancer},
  doi = {10.1186/s12885-021-07865-x},
  url = {https://doi.org/10.1186/s12885-021-07865-x}
}

RIS

TY  - JOUR
TI  - Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma.
AU  - Nell RJ
AU  - Menger NV
AU  - Versluis M
AU  - Luyten GPM
AU  - Verdijk RM
AU  - Madigan MC
AU  - Jager MJ
AU  - van der Velden PA
PY  - 2021
JO  - BMC cancer
DO  - 10.1186/s12885-021-07865-x
UR  - https://doi.org/10.1186/s12885-021-07865-x
ER  - 

APA

RJ, N., NV, M., M, V., GPM, L., RM, V., MC, M., MJ, J., & PA, V. D. V. (2021). Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma.. BMC cancer. https://doi.org/10.1186/s12885-021-07865-x

Source records